“Colchicine,” The Merck Index, Twelfth Edition, Merck & Co., Inc., Whitehouse Station, N.J., entry 2536, pp. 418-419 (1996). |
“Gambogic Acid,” The Merck Index, Twelfth Edition, Merck & Co., Inc., Whitehouse Station, N.J., entry 4373, p. 739 (1996). |
“Topotecan,” The Merck Index, Twelfth Edition, Merck & Co., Inc., Whitehouse Station, N.J., entry 9687, p. 1629 (1996). |
“ColBenemid® Tablets (Probenecid-Colchicine), U.S.P.,” Physicians' Desk Reference, 54th Edition, Medical Economics Company, Inc., Montvale, N.J., pp. 1759-1760 (2000). |
“Hycamtin® (hi-kam-tin) brand of topotecan hydrochloride for injection (for intravenous use),” Physicians' Desk Reference, 54th Edition, Medical Economics Company, Inc., Montvale, N.J., pp. 3006-3010 (2000). |
Adawadkar, P.D. et al., “Colouring Matters of Garcinia morella: Part VIII-Morellinol Dihydromorelloflavone & Morelloflavone-7”-β-glucoside, Indian J. Chem. 14B:19-21 (1976). |
Ahmad, S.A. et al., “Gamboge. Part II,” J. Chem. Soc. C:772-779 (1966). |
Asano, J. et al., “Cytotoxic Xanthones from Garcinia Hanburyi,” Phytochem. 41:815-820 (1996). |
Batteux, F. et al., “Gene Therapy of Experimental Autoimmune Thyroiditis by In Vivo Administration of Plasmid DNA Coding for Fas Ligand,” J. Immunol. 162 :603-608 (Jan. 1999). |
Bhat, H.B. et al., “The Colouring Matters of Garcinia morella: Part V-Isolation of Desoxymorellin & Dihydroisomorellin,” Indian J. Chem. 2:405-410 (1964). |
Boirivant, M. et al., “Laima Propria T Cells in Crohn's Disease and Other Gastrointestinal Inflammation Show Defective CD2 Pathway-Induced Apoptosis,” Gastroenterol. 116 :557-565 (Mar. 1999). |
Calabresi, P and B.A. Chabner, “Chemotherapy of Neoplastic Diseases,” Section X in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., The McGraw-Hill Companies, 1996, pp. 1225-1287 (1996). |
Cao, S-G. et al., “Novel Cytotoxic Polyprenylated Xanthonoids from Garcinia gaudichaudii (Guttiferae),” Tetrahedron 54:10915-10924 (1998). |
Cao, S-G. et al., “Cytotoxic Caged Tetraprenylated Xanthonoids from Garcinia gaudichaudii (Guttiferae),” Tetrahedron Lett. 390:3353-3356 (1998). |
Coven, T.R. et al., “PUVA-induced lymphocyte apoptosis: Mechanism of action in psoriasis,” Photodermatol. Phytoimmunol. Photomed. 15 :22-27 (Feb. 1999). |
Ellis, R.E. and H.R. Horovitz, “Two C. elegans genes control the programmed deaths of specific cells in the pharnyx,” Development 112:591-603 (1991). |
Ellis, R.E. et al., “Mechanisms and Functions of Cell Death,” Annu. Rev. Cell. Biol. 7:663-698 (1991). |
Friesen, C. et al., “Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells,” Nature Med. 2:574-577 (1996). |
Glücksmann, A., “Cell Deaths in Normal Vertebrate Ontogeny,”in Biological Reviews of the Cambridge Philosophical Society, H.M. Fox, ed., University Press, 1951, pp. 59-86. |
Glücksmann, A., “Cell death in normal development,”0 Arch. Bio. 76:419-437 (1965). |
Heenen, M. et al., “Methotrexate induces apoptotic cell death in human keratinocytes,” Arch. Dermatol. Res. 290:240-245 (1998). |
Infante, A.J. et al., “The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation the impairs lymphocyte apoptosis,” J. Pediatrics 133:629-633 (1998). |
Karanjgaonkar, C.G. et al., “Morellic, Isomorellic and Gambogic Acids,” Tetrahedron Lett. 687-691 (1966). |
Leong, Y.-W. et al., “Forbesione, a Modified Xanthone from Garcinia forbesii,” J. Chem. Res. S:392-393 (1996). |
Lin, L.-J. et al., “Isogambogic acid and Isomorellinol from Garcinia hanburyi,” Magnetic Resonance Chem. 31340-347 (1993). |
Los, M. et al., “Cross-Resistance of CD95- and Drug-Induced Apoptosis as a Consequence of Deficient Activation of Caspases (ICE/Ced-3 Proteases),” Blood 90:3118-3129 (1997). |
Lu, G.-B. et al., “Isolation and Structure of Neo-Gambogic Acid From Gamboge Garcinia hanburryi),” Acta Pharmaceutica Sinica 19:636-639 (1984). |
Lu, G. et al., “Isolation and structure of neo-gambogic acid from gamboge (Garcinia hanburryi),” Chem Abs. 102:21181 (1984). |
Ohsako, S. and K.B. Elkon,“Apoptosis in the effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis,” Cell Death Differentiation 6:13-21 (Jan. 1999). |
Ollis, W.D. et al., “The Constitution of Gambogic Acid,” Tetrahedron 21:1453-1470 (1965). |
O'Reilly, L.A. and A. Strasser, “Apoptosis and autoimmune disease,” Inflamm. Res. 48:5-21 (Jan. 1999). |
Orrenius, S., “Apoptosis: molecular mechanisms and implications for human disease,” J. Internal Med. 237:529-536 (1995). |
Ozawa, M. et al., “312-nanometer Ultraviolet B Light (Narrow-Band UVB) Induces Apoptosis of T Cells within Psoriatic Lesions,” J. Exp. Med. 189:711-718 (Feb. 1999). |
Rao, G.S.R.S. et al., “Structure of moreollin, a pigment isolated from Garcinia morella Desser,” Proc. Indian Acad. Sci. 87:75-86 (1978). |
Savill, J., “Apoptosis in resolution of inflammation,” J. Leukocyte Biol. 61:375-380 (1997). |
Schmitt, E. et al., “The Bcl-xL and Bax-α control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation,” Biochem. Cell Biol. 75:301-314 (1997). |
Thornberry, N.A., “The capase family of cysteine proteases,” Br. Med. Bull. 53:478-490 (1996). |
Thornberry, N.A., “Caspases: key mediators of apoptosis,” Chemistry & Biology 5:R97-R103 (1998). |
Vaishnaw, A.K. et al., “The molecular basis from apoptotic defects in patients with CD95 (Fas/Apo-1) mutations,” J. Clin. Invest. 103: 355-363 (Feb. 1999). |
Vaux, D. et al. ,“An Evolutionary Perspective on Apoptosis,” Cell 76:777-779 (1994). |
Wakisaka, S. et al., “Modulation by proinflammatory cytokines of Fas.Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA),” Clin. Exp. Immunol. 114:119-128 (1998). |
Wylie, A.H., “Cell Death: a new classification separating apoptosis from necrosis,” in Cell death in biology and pathology, Bowen, I.D. and R.A. Lockshin, eds., Chapman and Hall, 1981, pp. 9-34. |
Wylie, A.H. et al., “Cell Death: The Significance of Apoptosis,” Intl. Rev. Cytol. 68:251-306 (1980). |
Yates, P. et al., “Acetyl-α-Gambogic Acid,” Tetrahedron Lett. 1623-1629 (1963). |
Zhou, T. et al., “Bisindolymaleimide VIII facilitates Fas-mediated apoptosis and Inhibits T cell-mediated autoimmune diseases,” Nature Med. 5:42-48 (Jan. 1999). |
International Search Report for International Application PCT/US00/02332, mailed Jun. 27, 2000. |